Document is current
Any future updates will be listed below
-
Authors
Yamashita, Motoi https://orcid.org/0000-0002-9814-1033
Ogawa, Chihiro
Zhang, Baihao https://orcid.org/0000-0002-3456-2509
Kobayashi, Tetsuro
Nomura, Aneela https://orcid.org/0000-0002-0572-2358
Barker, Clive
Zou, Chengcheng
Yamanaka, Satoshi https://orcid.org/0000-0001-8825-7481
Hayashi, Ken-ichiro
Shinkai, Yoichi https://orcid.org/0000-0002-6051-2484
Moro, Kazuyo
Fargarasan, Sidonia https://orcid.org/0000-0003-2086-6402
Imami, Koshi https://orcid.org/0000-0002-7451-4982
Seita, Jun https://orcid.org/0000-0002-3008-3615
Shirai, Fumiyuki https://orcid.org/0000-0003-0593-2467
Sawasaki, Tatsuya https://orcid.org/0000-0002-7952-0556
Kanemaki, Masato T. https://orcid.org/0000-0002-7657-1649
Taniuchi, Ichiro https://orcid.org/0000-0002-9853-9068
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (19H05747)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 5 November 2024
First Online: 29 November 2024
Competing interests
: I.T., M.T.K., and K.H. are co-inventors to a patent application for Rosa26OsTIR1(F74G) transgenic mouse; patent applicant: RIKEN, National Institute of Genetics, and Okayama University of Science; name of inventors: I.T., M.T.K., and K.H.; application number: 2023-036211 (Examination, Japan); specific aspect of manuscript covered in patent application; Utility of Rosa26OsTIR1(F74G) transgenic mouse. The remaining authors declare no competing interests.
